Technology
W. L. Gore & Associates (Gore) announced that the FDA granted approval for the use of GORE HELEX Septal Occluder with a modified catheter delivery system indicated for the transcatheter closure of atrial septal defect (ASD), providing a percutaneous ASD closure solution for very young patients.
February 19, 2008
News
February 20, 2008 - At HIMSS 2008, Siemens Healthcare will emphasize its image data management solutions for radiology ...
February 19, 2008
Technology
Toshiba America Medical Systems Inc. recently introduced its Infinix VF-i/SP X-ray system, a universal cardiovascular ...
February 19, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
February 19, 2008 – The American College of Cardiology (ACC) urges the medical community to oppose cuts to medical ...
February 18, 2008News
February 19, 2008 - Boston Scientific Corp. closed the sale of its Fluid Management and Venous Access businesses to ...
February 18, 2008News
February 19, 2008 - A new study released today found pending congressional legislation seeking the mandatory disclosure ...
February 18, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
February 19, 2008 - Among patients with acute myocardial infarction (AMI), prior statin therapy is associated with better perfusion after primary angioplasty of the infarct-related artery, according to a report in the January 15 issue of the American Journal of Cardiology.
February 18, 2008News
February 19, 2008 – The first CE certified Nobori Drug-Eluting Coronary Stent System was successfully implanted in Europe, as Terumo Corp. is poised to expand the product from spring 2008 to more than 20 countries in Europe, Asia, New Zealand and Africa.
February 18, 2008News
February 19, 2008 - A regimen of aspirin, clopidogrel and coumadin started at discharge decreased mortality and major adverse cardiac events (MACE) while keeping bleeding to acceptable levels in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) with stent placement, reports a study in the February 26, 2008 issue of the Journal of the American College of Car
February 18, 2008Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
February 19, 2008 – A novel, fully bioabsorbable salicylate-based stent offers the potential to reduce adverse events associated with current drug-eluting stents (DES) and could be very beneficial to patients with coronary heart disease, according to a presentation at the Cardiovascular Revascularization Therapies 2008 (CRT) symposium.
February 18, 2008News
February 19, 2008 – Clinicians implanted the BioMatrix drug-eluting stent system into the first European patients in a live broadcast during the Joint Interventional Meeting (JIM), held in Rome, Italy, from February 13-15. The BioMatrix drug-eluting stent system, by Biosensors International Group Ltd., combines a biodegradable PLA and the company’s proprietary limus drug, Biolimus A9.
February 18, 2008News
February 18, 2008 - Abbott received FDA approval for SIMCOR a fixed-dose combination of two cholesterol therapies, Niaspan (Abbott’s proprietary niacin extended-release) and simvastatin, offering patients a new option for reaching healthy lipid levels.
February 17, 2008Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
Siemens Healthcare will highlight the Magnetom Essenza which features 30 mT/m gradients, reportedly delivering excellent ...
February 17, 2008News
February 18, 2008 – OrbusNeich’s Genous Bio-engineered R stent is feasible and safe for use in acute myocardial infarction (AMI) patients, according to a paper published in the American Heart Journal (2008; Vol. 155, Issue 1: 128-132).
February 17, 2008News
February 18, 2008 - Treating patients who have occlusive femoropopliteal disease with paclitaxel-coated balloons during ...
February 17, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now